Does hepatitis B vaccination reduce the risk of HBV reactivation associated with immunosuppressive therapy?

Topics: Rheumatology • General Rheumatology • Vaccines • Hepatitis

For example, in patients who are HbSAg negative, anti-HBc positive and HbSAb negative, does vaccination reduce reactivation risk?

Answer from: at Academic Institution

Hepatitis B reactivation is a critical concern when patients are undergoing immunosuppressive therapy, often described as 'deadly but preventable.' Screening for HBV is strongly advised before initiating biologic therapies, targeted synthetic therapies, or high-dose immunosuppression, including HBsA...

Comments

at Uniformed Services University of the Health Sciences (USUHS)
@Leonard Calabreseand @Cassandra Calabrese: Does t...

Answer from: at Academic Institution

Thanks for the question and we apologize that our answer reads somewhat ambiguously as the answer to that is NO we do not vaccinate isolated anti-HBcore patients- we reworded our 'answer' to this question which we believe is clearer.

Comments

at Uniformed Services University of the Health Sciences (USUHS)
Thanks for the clarification, Len, @Leonard Calabr...

Related Questions